WASHINGTON, DC — The survival benefit for contralateral prophylactic mastectomy among women who do not have a BRCA gene mutation is less than 1% at 20 years, a new computer model suggests. "We hope ...

Oral Uracil and Tegafur Compared With Classic Cyclophosphamide, Methotrexate, Fluorouracil As Postoperative Chemotherapy in Patients With Node-Negative, High-Risk Breast Cancer: National Surgical ...

Overall, 71% (n = 684) of eligible women responded to the mailed survey. Of those who responded to the survey, 81% (n = 554) responded to one or both of the open-ended questions. Of the total 1,067 ...

Randomized Phase II Trial of the Efficacy and Safety of Trastuzumab Combined With Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Administered As ...

BRCA carriers had similar overall and breast cancer-specific survival with risk-reducing mastectomy or surveillance. Risk-reducing mastectomy reduced breast cancer incidence by 94% compared with ...

DURING AND AFTER THAT LIFE CHANGING BREAST CANCER DIAGNOSIS IS DIFFERENT. TREATMENT AND PREVENTION MAY REQUIRE A SPECIFIC SURGICAL PROCEDURE CALLED A MASTECTOMY. BOARD CERTIFIED PLASTIC SURGEON DOCTOR ...

Original Medicare (parts A and B) and Medicare Advantage (Part C) both provide coverage for medically necessary double mastectomies, including reconstruction and prosthesis surgery. Original Medicare ...

The use of contralateral prophylactic mastectomy (CPM), the surgical removal of a breast unaffected by cancer as part of the course of treatment for breast cancer, has more than tripled from 2002 to ...

While mastectomy is often a necessary and life-saving treatment option for many women with breast cancer, the surgery may contribute to worse sexual health, body image, and several other physical and ...

Choosing between a single mastectomy and double (bilateral) mastectomy for breast cancer can be challenging, and the right decision is different for each person. Medical concerns to weigh include your ...